tricalcium phosphate has been researched along with Hyperphosphatemia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, RJ; Kim, SC; Paik, JM; Schneeweiss, S; Spoendlin, J; Tsacogianis, T | 1 |
| Chen, W; Hu, Z; Jiang, JL; Li, Y; Liu, GY; Ni, LJ; Ren, W; Su, KL; Wang, K; Zhou, CP | 1 |
| Ahmad, Z; Gupta, AK; Mallick, S; Mathur, SR | 1 |
| Agarwal, B; Davenport, A; Shaw, S; Walecka, A | 1 |
| Hu, XP; Jin, CL; Li, Y; Shao, Y; Wang, H; Wang, HP; Yu, C; Yuan, GJ; Zhang, C; Zhang, L; Zhao, YK; Zhou, L; Zhu, QG | 1 |
| Coresh, J; Fink, NE; Huang, CX; Melamed, ML; Plantinga, LC; Powe, NR | 1 |
| Agrawal, N; McChesney, LP; Nair, R; Suneja, M; Thomas, CP; Tuteja, S | 1 |
| Culleton, B; Hemmelgarn, B; Klarenbach, S; Manns, BJ; Tonelli, M; Walsh, M | 1 |
| Jander, A; Kałuzyńska, A; Tkaczyk, M | 1 |
| Mason, MA; Shepler, BM | 1 |
| Demer, LL; Lu, J; Sage, AP; Tintut, Y | 1 |
| Adamcewicz, M; Bearelly, D; Friedenberg, FK; Porat, G | 1 |
| Culleton, B; Klarenbach, S; Lee, H; Manns, B; Shrive, F; Tonelli, M; Wiebe, N | 1 |
| Dobashi, Y; Hirawa, N; Iwatsubo, K; Iwatsubo, M; Kawaguchi, Y; Kokuho, T; Nakazawa, A; Ohnishi, T; Takeda, H; Tamura, K; Toya, Y; Umemura, S; Yasuda, G | 1 |
| Abdullah, S; Abla, O; Diezi, M; Dupuis, LL; Geary, D; Sung, L | 1 |
| Alesutan, I; Amann, K; Eckardt, KU; Kuro-O, M; Lang, F; Pasch, A; Pieske, B; Voelkl, J | 1 |
| Czekuć-Kryskiewicz, E; Karczmarewicz, E; Lorenc, RS | 1 |
| Kuro-o, M | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Ehrenpreis, ED | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
5 review(s) available for tricalcium phosphate and Hyperphosphatemia
| Article | Year |
|---|---|
Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Topics: Calcinosis; Calcium; Calcium Phosphates; Calcium, Dietary; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Disease Progression; Humans; Hyperphosphatemia; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Mechanism of action and toxicities of purgatives used for colonoscopy preparation.
Topics: Ascorbic Acid; Calcium Phosphates; Cathartics; Citric Acid; Colonic Neoplasms; Colonoscopy; Humans; Hyperphosphatemia; Hypocalcemia; Nephrocalcinosis; Organometallic Compounds; Phosphates; Preoperative Care; Randomized Controlled Trials as Topic; Therapeutic Irrigation | 2011 |
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
Topics: Calcium; Calcium Phosphates; Chelating Agents; Drug Design; Humans; Hyperphosphatemia; Kidney; Kidney Diseases; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Safety; Sevelamer; Treatment Outcome | 2007 |
Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.
Topics: Animals; Calcium Phosphates; Cell Transdifferentiation; Chondrocytes; Gene Expression Regulation; Humans; Hyperphosphatemia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Osteoblasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification | 2019 |
[Pathologies of calcium-phosphate homeostasis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Bone and Bones; Calcitriol; Calcium Phosphates; Disease Progression; Fibroblast Growth Factor-23; Homeostasis; Humans; Hyperphosphatemia; Kidney; Parathyroid Glands; Parathyroid Hormone; Renal Insufficiency, Chronic; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Up-Regulation; Vitamin D | 2012 |
3 trial(s) available for tricalcium phosphate and Hyperphosphatemia
| Article | Year |
|---|---|
The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
Topics: Adult; Aged; Appointments and Schedules; Calcinosis; Calcium; Calcium Phosphates; Circadian Rhythm; Combined Modality Therapy; Female; Hemodialysis, Home; Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphates; Risk Factors | 2010 |
Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Calcium; Calcium Phosphates; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphates; Polyamines; Regression Analysis; Renal Dialysis; Sevelamer | 2007 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
13 other study(ies) available for tricalcium phosphate and Hyperphosphatemia
| Article | Year |
|---|---|
Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.
Topics: Aged; Calcinosis; Calcium Phosphates; Chelating Agents; Cohort Studies; Coronary Artery Disease; Female; Humans; Hyperphosphatemia; Male; Propensity Score; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; United States | 2019 |
The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia.
Topics: Adult; Aged; Anemia; Calcium Phosphates; Erythropoietin; Female; Health Status; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Mental Health; Middle Aged; Parathyroid Hormone; Quality of Life; Renal Dialysis | 2013 |
Hyperphosphatemic tumoral calcinosis.
Topics: Adult; Calcinosis; Calcium Phosphates; Elbow; Elbow Joint; Hip; Hip Joint; Humans; Hyperphosphatemia; Male; Phosphates; Young Adult | 2013 |
Is parenteral phosphate replacement in the intensive care unit safe?
Topics: Calcium; Calcium Phosphates; Female; Humans; Hyperphosphatemia; Hypophosphatemia; Intensive Care Units; Male; Middle Aged; Phosphates; Prospective Studies; Renal Replacement Therapy; Time Factors; Treatment Outcome | 2014 |
Establishment and characterization of a rat model of hyperphosphatemia.
Topics: Animals; Bone Density; Calcium Phosphates; Creatinine; Disease Models, Animal; Femur; Hyperphosphatemia; Kidney; Parathyroid Hormone; Radiography; Rats, Sprague-Dawley | 2015 |
Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study.
Topics: Aged; Blood Pressure; Calcium; Calcium Phosphates; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Hypertension, Renal; Incidence; Kidney Failure, Chronic; Longitudinal Studies; Male; Phosphates; Predictive Value of Tests; Renal Dialysis; Risk Factors | 2008 |
Unrecognized acute phosphate nephropathy in a kidney donor with consequent poor allograft outcome.
Topics: Acute Disease; Adult; Aged; Calcium Phosphates; Delayed Graft Function; Female; Humans; Hyperphosphatemia; Kidney Diseases; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Phosphates; Phosphorus; Tissue Donors | 2009 |
[Calcium-phosphate disturbances in dialysed children and adolescents--one centre analysis between 1991-2008].
Topics: Adolescent; Bone and Bones; Calcinosis; Calcitriol; Calcium Phosphates; Child; Child, Preschool; Female; Humans; Hyperparathyroidism; Hyperphosphatemia; Infant; Infant, Newborn; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Renal Dialysis; Retrospective Studies; Survival Rate; Vitamin D | 2010 |
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.
Topics: Animals; Base Sequence; Bone Morphogenetic Protein 2; Calcinosis; Calcium Phosphates; Cell Differentiation; Cell Line; DNA Primers; Hyperphosphatemia; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Myocytes, Smooth Muscle; Nanoparticles; Osteogenesis; Osteopontin; Up-Regulation | 2011 |
Sevelamer hydrochloride: a novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children.
Topics: Adolescent; Calcium Phosphates; Chelating Agents; Child; Child, Preschool; Female; Humans; Hyperphosphatemia; Male; Phosphates; Polyamines; Retrospective Studies; Sevelamer; Treatment Outcome; Tumor Lysis Syndrome; Vomiting | 2008 |
Calciprotein particle (CPP): a true culprit of phosphorus woes?
Topics: alpha-2-HS-Glycoprotein; Calcium Phosphates; Crystallization; Humans; Hyperphosphatemia; Nanoparticles; Phosphorus; Phosphorus, Dietary; Protein Binding; Renal Insufficiency, Chronic | 2014 |
Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.
Topics: Albumins; alpha-2-HS-Glycoprotein; Animals; Calcium Phosphates; Cells, Cultured; Diet, Protein-Restricted; Hyperphosphatemia; Male; Muscle, Smooth, Vascular; Phosphorus, Dietary; Protein-Energy Malnutrition; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Uremia; Vascular Calcification | 2015 |
Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis.
Topics: Adult; Body Composition; Calcium Phosphates; Cathartics; Colonoscopy; Electrolytes; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphates; Risk Factors; Therapeutic Irrigation; Weight Loss | 2009 |